Hydrolase, Uncharacterized
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 18 |
NetGPI | no | yes: 0, no: 18 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005929 | cilium | 4 | 19 |
GO:0042995 | cell projection | 2 | 19 |
GO:0043226 | organelle | 2 | 19 |
GO:0043227 | membrane-bounded organelle | 3 | 19 |
GO:0110165 | cellular anatomical entity | 1 | 19 |
GO:0120025 | plasma membrane bounded cell projection | 3 | 19 |
GO:0005743 | mitochondrial inner membrane | 5 | 1 |
GO:0016020 | membrane | 2 | 2 |
GO:0019866 | organelle inner membrane | 4 | 1 |
GO:0031090 | organelle membrane | 3 | 1 |
GO:0031966 | mitochondrial membrane | 4 | 1 |
GO:0000151 | ubiquitin ligase complex | 3 | 1 |
GO:0019005 | SCF ubiquitin ligase complex | 5 | 1 |
GO:0031461 | cullin-RING ubiquitin ligase complex | 4 | 1 |
GO:0032991 | protein-containing complex | 1 | 1 |
GO:0140535 | intracellular protein-containing complex | 2 | 1 |
GO:1902494 | catalytic complex | 2 | 1 |
GO:1990234 | transferase complex | 3 | 1 |
Related structures:
AlphaFold database: E9AGT5
Term | Name | Level | Count |
---|---|---|---|
GO:0006950 | response to stress | 2 | 1 |
GO:0006952 | defense response | 3 | 1 |
GO:0050896 | response to stimulus | 1 | 1 |
GO:0006468 | protein phosphorylation | 5 | 1 |
GO:0006793 | phosphorus metabolic process | 3 | 2 |
GO:0006796 | phosphate-containing compound metabolic process | 4 | 2 |
GO:0006807 | nitrogen compound metabolic process | 2 | 2 |
GO:0008152 | metabolic process | 1 | 3 |
GO:0009987 | cellular process | 1 | 3 |
GO:0016310 | phosphorylation | 5 | 2 |
GO:0019538 | protein metabolic process | 3 | 2 |
GO:0036211 | protein modification process | 4 | 1 |
GO:0043170 | macromolecule metabolic process | 3 | 2 |
GO:0043412 | macromolecule modification | 4 | 1 |
GO:0044237 | cellular metabolic process | 2 | 3 |
GO:0044238 | primary metabolic process | 2 | 2 |
GO:0071704 | organic substance metabolic process | 2 | 2 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 2 |
GO:0006508 | proteolysis | 4 | 1 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 7 | 1 |
GO:0009056 | catabolic process | 2 | 1 |
GO:0009057 | macromolecule catabolic process | 4 | 1 |
GO:0010498 | proteasomal protein catabolic process | 5 | 1 |
GO:0019941 | modification-dependent protein catabolic process | 6 | 1 |
GO:0030163 | protein catabolic process | 4 | 1 |
GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process | 7 | 1 |
GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process | 6 | 1 |
GO:0043632 | modification-dependent macromolecule catabolic process | 5 | 1 |
GO:0044248 | cellular catabolic process | 3 | 1 |
GO:0044260 | obsolete cellular macromolecule metabolic process | 3 | 1 |
GO:0044265 | obsolete cellular macromolecule catabolic process | 4 | 1 |
GO:0051603 | proteolysis involved in protein catabolic process | 5 | 1 |
GO:1901565 | organonitrogen compound catabolic process | 4 | 1 |
GO:1901575 | organic substance catabolic process | 3 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 6 |
GO:0016787 | hydrolase activity | 2 | 4 |
GO:0005488 | binding | 1 | 2 |
GO:0043167 | ion binding | 2 | 2 |
GO:0043169 | cation binding | 3 | 1 |
GO:0046872 | metal ion binding | 4 | 1 |
GO:0000166 | nucleotide binding | 3 | 1 |
GO:0004672 | protein kinase activity | 3 | 1 |
GO:0005524 | ATP binding | 5 | 1 |
GO:0016301 | kinase activity | 4 | 2 |
GO:0016740 | transferase activity | 2 | 2 |
GO:0016772 | transferase activity, transferring phosphorus-containing groups | 3 | 2 |
GO:0016773 | phosphotransferase activity, alcohol group as acceptor | 4 | 1 |
GO:0017076 | purine nucleotide binding | 4 | 1 |
GO:0030554 | adenyl nucleotide binding | 5 | 1 |
GO:0032553 | ribonucleotide binding | 3 | 1 |
GO:0032555 | purine ribonucleotide binding | 4 | 1 |
GO:0032559 | adenyl ribonucleotide binding | 5 | 1 |
GO:0035639 | purine ribonucleoside triphosphate binding | 4 | 1 |
GO:0036094 | small molecule binding | 2 | 1 |
GO:0043168 | anion binding | 3 | 1 |
GO:0097159 | organic cyclic compound binding | 2 | 1 |
GO:0097367 | carbohydrate derivative binding | 2 | 1 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 1 |
GO:1901265 | nucleoside phosphate binding | 3 | 1 |
GO:1901363 | heterocyclic compound binding | 2 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 238 | 242 | PF00656 | 0.557 |
CLV_NRD_NRD_1 | 158 | 160 | PF00675 | 0.470 |
CLV_NRD_NRD_1 | 290 | 292 | PF00675 | 0.298 |
CLV_PCSK_KEX2_1 | 158 | 160 | PF00082 | 0.476 |
CLV_PCSK_KEX2_1 | 290 | 292 | PF00082 | 0.298 |
CLV_PCSK_SKI1_1 | 158 | 162 | PF00082 | 0.475 |
CLV_PCSK_SKI1_1 | 3 | 7 | PF00082 | 0.490 |
CLV_PCSK_SKI1_1 | 310 | 314 | PF00082 | 0.455 |
CLV_PCSK_SKI1_1 | 380 | 384 | PF00082 | 0.497 |
CLV_Separin_Metazoa | 477 | 481 | PF03568 | 0.301 |
DEG_APCC_DBOX_1 | 290 | 298 | PF00400 | 0.489 |
DEG_APCC_KENBOX_2 | 70 | 74 | PF00400 | 0.315 |
DOC_CDC14_PxL_1 | 447 | 455 | PF14671 | 0.495 |
DOC_CYCLIN_RxL_1 | 310 | 323 | PF00134 | 0.434 |
DOC_CYCLIN_RxL_1 | 451 | 462 | PF00134 | 0.517 |
DOC_CYCLIN_yClb5_NLxxxL_5 | 337 | 346 | PF00134 | 0.313 |
DOC_MAPK_gen_1 | 158 | 168 | PF00069 | 0.490 |
DOC_MAPK_gen_1 | 287 | 297 | PF00069 | 0.422 |
DOC_MAPK_gen_1 | 310 | 320 | PF00069 | 0.437 |
DOC_MAPK_gen_1 | 377 | 387 | PF00069 | 0.528 |
DOC_MAPK_gen_1 | 69 | 77 | PF00069 | 0.397 |
DOC_MAPK_MEF2A_6 | 100 | 107 | PF00069 | 0.438 |
DOC_MAPK_MEF2A_6 | 158 | 167 | PF00069 | 0.365 |
DOC_MAPK_MEF2A_6 | 471 | 478 | PF00069 | 0.528 |
DOC_MAPK_MEF2A_6 | 63 | 70 | PF00069 | 0.336 |
DOC_MAPK_NFAT4_5 | 158 | 166 | PF00069 | 0.368 |
DOC_MIT_MIM_1 | 155 | 163 | PF04212 | 0.376 |
DOC_PP2B_LxvP_1 | 129 | 132 | PF13499 | 0.420 |
DOC_PP2B_LxvP_1 | 517 | 520 | PF13499 | 0.566 |
DOC_PP4_FxxP_1 | 253 | 256 | PF00568 | 0.380 |
DOC_USP7_MATH_1 | 246 | 250 | PF00917 | 0.516 |
DOC_USP7_MATH_1 | 308 | 312 | PF00917 | 0.259 |
DOC_USP7_MATH_1 | 452 | 456 | PF00917 | 0.523 |
DOC_USP7_MATH_1 | 553 | 557 | PF00917 | 0.768 |
DOC_USP7_MATH_1 | 84 | 88 | PF00917 | 0.536 |
DOC_WW_Pin1_4 | 264 | 269 | PF00397 | 0.469 |
DOC_WW_Pin1_4 | 439 | 444 | PF00397 | 0.529 |
DOC_WW_Pin1_4 | 510 | 515 | PF00397 | 0.566 |
LIG_14-3-3_CanoR_1 | 100 | 106 | PF00244 | 0.426 |
LIG_14-3-3_CanoR_1 | 188 | 192 | PF00244 | 0.448 |
LIG_14-3-3_CanoR_1 | 218 | 224 | PF00244 | 0.502 |
LIG_14-3-3_CanoR_1 | 248 | 253 | PF00244 | 0.414 |
LIG_14-3-3_CanoR_1 | 279 | 284 | PF00244 | 0.481 |
LIG_14-3-3_CanoR_1 | 347 | 352 | PF00244 | 0.467 |
LIG_Actin_WH2_2 | 369 | 385 | PF00022 | 0.446 |
LIG_Actin_WH2_2 | 486 | 502 | PF00022 | 0.516 |
LIG_BIR_III_2 | 203 | 207 | PF00653 | 0.380 |
LIG_BIR_III_2 | 449 | 453 | PF00653 | 0.470 |
LIG_BIR_III_2 | 80 | 84 | PF00653 | 0.423 |
LIG_DLG_GKlike_1 | 279 | 286 | PF00625 | 0.363 |
LIG_DLG_GKlike_1 | 347 | 354 | PF00625 | 0.313 |
LIG_FHA_1 | 102 | 108 | PF00498 | 0.539 |
LIG_FHA_1 | 197 | 203 | PF00498 | 0.516 |
LIG_FHA_1 | 40 | 46 | PF00498 | 0.456 |
LIG_FHA_1 | 525 | 531 | PF00498 | 0.529 |
LIG_FHA_1 | 539 | 545 | PF00498 | 0.532 |
LIG_FHA_2 | 150 | 156 | PF00498 | 0.418 |
LIG_FHA_2 | 333 | 339 | PF00498 | 0.473 |
LIG_FHA_2 | 366 | 372 | PF00498 | 0.481 |
LIG_FHA_2 | 404 | 410 | PF00498 | 0.528 |
LIG_FHA_2 | 411 | 417 | PF00498 | 0.483 |
LIG_LIR_Apic_2 | 251 | 256 | PF02991 | 0.368 |
LIG_LIR_Apic_2 | 440 | 444 | PF02991 | 0.412 |
LIG_LIR_Gen_1 | 209 | 217 | PF02991 | 0.199 |
LIG_LIR_Gen_1 | 4 | 14 | PF02991 | 0.386 |
LIG_LIR_Gen_1 | 409 | 418 | PF02991 | 0.363 |
LIG_LIR_Nem_3 | 209 | 213 | PF02991 | 0.188 |
LIG_LIR_Nem_3 | 4 | 9 | PF02991 | 0.455 |
LIG_LIR_Nem_3 | 409 | 415 | PF02991 | 0.480 |
LIG_LIR_Nem_3 | 80 | 85 | PF02991 | 0.569 |
LIG_LYPXL_yS_3 | 82 | 85 | PF13949 | 0.407 |
LIG_RPA_C_Fungi | 274 | 286 | PF08784 | 0.295 |
LIG_SH2_CRK | 441 | 445 | PF00017 | 0.426 |
LIG_SH2_STAT5 | 113 | 116 | PF00017 | 0.472 |
LIG_SH2_STAT5 | 317 | 320 | PF00017 | 0.487 |
LIG_SH2_STAT5 | 8 | 11 | PF00017 | 0.591 |
LIG_SH3_3 | 143 | 149 | PF00018 | 0.371 |
LIG_Sin3_3 | 74 | 81 | PF02671 | 0.323 |
LIG_SUMO_SIM_anti_2 | 488 | 495 | PF11976 | 0.395 |
LIG_SUMO_SIM_par_1 | 164 | 170 | PF11976 | 0.448 |
LIG_SUMO_SIM_par_1 | 500 | 505 | PF11976 | 0.502 |
LIG_TRAF2_1 | 233 | 236 | PF00917 | 0.593 |
LIG_TYR_ITIM | 315 | 320 | PF00017 | 0.313 |
LIG_WW_3 | 472 | 476 | PF00397 | 0.391 |
MOD_CDC14_SPxK_1 | 513 | 516 | PF00782 | 0.438 |
MOD_CDK_SPxK_1 | 510 | 516 | PF00069 | 0.436 |
MOD_CDK_SPxxK_3 | 264 | 271 | PF00069 | 0.368 |
MOD_CK1_1 | 101 | 107 | PF00069 | 0.538 |
MOD_CK1_1 | 230 | 236 | PF00069 | 0.640 |
MOD_CK1_1 | 332 | 338 | PF00069 | 0.367 |
MOD_CK1_1 | 350 | 356 | PF00069 | 0.196 |
MOD_CK1_1 | 366 | 372 | PF00069 | 0.271 |
MOD_CK1_1 | 403 | 409 | PF00069 | 0.440 |
MOD_CK1_1 | 462 | 468 | PF00069 | 0.548 |
MOD_CK1_1 | 488 | 494 | PF00069 | 0.468 |
MOD_CK1_1 | 508 | 514 | PF00069 | 0.538 |
MOD_CK2_1 | 230 | 236 | PF00069 | 0.676 |
MOD_CK2_1 | 332 | 338 | PF00069 | 0.455 |
MOD_CK2_1 | 365 | 371 | PF00069 | 0.437 |
MOD_CK2_1 | 422 | 428 | PF00069 | 0.508 |
MOD_CK2_1 | 462 | 468 | PF00069 | 0.549 |
MOD_DYRK1A_RPxSP_1 | 510 | 514 | PF00069 | 0.433 |
MOD_GlcNHglycan | 236 | 240 | PF01048 | 0.705 |
MOD_GlcNHglycan | 264 | 267 | PF01048 | 0.525 |
MOD_GlcNHglycan | 310 | 313 | PF01048 | 0.452 |
MOD_GlcNHglycan | 37 | 40 | PF01048 | 0.505 |
MOD_GlcNHglycan | 386 | 390 | PF01048 | 0.484 |
MOD_GlcNHglycan | 424 | 427 | PF01048 | 0.489 |
MOD_GlcNHglycan | 494 | 497 | PF01048 | 0.528 |
MOD_GSK3_1 | 230 | 237 | PF00069 | 0.641 |
MOD_GSK3_1 | 33 | 40 | PF00069 | 0.520 |
MOD_GSK3_1 | 365 | 372 | PF00069 | 0.470 |
MOD_GSK3_1 | 422 | 429 | PF00069 | 0.442 |
MOD_GSK3_1 | 452 | 459 | PF00069 | 0.458 |
MOD_GSK3_1 | 488 | 495 | PF00069 | 0.426 |
MOD_GSK3_1 | 504 | 511 | PF00069 | 0.288 |
MOD_GSK3_1 | 524 | 531 | PF00069 | 0.545 |
MOD_N-GLC_1 | 459 | 464 | PF02516 | 0.384 |
MOD_N-GLC_1 | 505 | 510 | PF02516 | 0.560 |
MOD_N-GLC_2 | 343 | 345 | PF02516 | 0.423 |
MOD_N-GLC_2 | 482 | 484 | PF02516 | 0.504 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.491 |
MOD_NEK2_1 | 196 | 201 | PF00069 | 0.473 |
MOD_NEK2_1 | 222 | 227 | PF00069 | 0.498 |
MOD_NEK2_1 | 234 | 239 | PF00069 | 0.638 |
MOD_NEK2_1 | 318 | 323 | PF00069 | 0.356 |
MOD_NEK2_1 | 33 | 38 | PF00069 | 0.663 |
MOD_NEK2_1 | 363 | 368 | PF00069 | 0.375 |
MOD_NEK2_1 | 410 | 415 | PF00069 | 0.383 |
MOD_NEK2_1 | 456 | 461 | PF00069 | 0.389 |
MOD_NEK2_1 | 504 | 509 | PF00069 | 0.493 |
MOD_NEK2_1 | 538 | 543 | PF00069 | 0.693 |
MOD_NEK2_1 | 98 | 103 | PF00069 | 0.423 |
MOD_NEK2_2 | 140 | 145 | PF00069 | 0.499 |
MOD_NEK2_2 | 426 | 431 | PF00069 | 0.361 |
MOD_OFUCOSY | 97 | 102 | PF10250 | 0.399 |
MOD_PIKK_1 | 222 | 228 | PF00454 | 0.543 |
MOD_PIKK_1 | 329 | 335 | PF00454 | 0.403 |
MOD_PIKK_1 | 400 | 406 | PF00454 | 0.514 |
MOD_PK_1 | 248 | 254 | PF00069 | 0.501 |
MOD_PKA_2 | 187 | 193 | PF00069 | 0.389 |
MOD_PKA_2 | 217 | 223 | PF00069 | 0.508 |
MOD_PKA_2 | 278 | 284 | PF00069 | 0.502 |
MOD_PKA_2 | 366 | 372 | PF00069 | 0.465 |
MOD_Plk_1 | 408 | 414 | PF00069 | 0.425 |
MOD_Plk_1 | 416 | 422 | PF00069 | 0.370 |
MOD_Plk_1 | 459 | 465 | PF00069 | 0.472 |
MOD_Plk_1 | 488 | 494 | PF00069 | 0.477 |
MOD_Plk_1 | 504 | 510 | PF00069 | 0.470 |
MOD_Plk_1 | 528 | 534 | PF00069 | 0.538 |
MOD_Plk_1 | 98 | 104 | PF00069 | 0.534 |
MOD_Plk_2-3 | 187 | 193 | PF00069 | 0.297 |
MOD_Plk_4 | 206 | 212 | PF00069 | 0.264 |
MOD_Plk_4 | 248 | 254 | PF00069 | 0.444 |
MOD_Plk_4 | 369 | 375 | PF00069 | 0.497 |
MOD_ProDKin_1 | 264 | 270 | PF00069 | 0.463 |
MOD_ProDKin_1 | 439 | 445 | PF00069 | 0.542 |
MOD_ProDKin_1 | 510 | 516 | PF00069 | 0.436 |
TRG_DiLeu_LyEn_5 | 181 | 186 | PF01217 | 0.371 |
TRG_ENDOCYTIC_2 | 317 | 320 | PF00928 | 0.487 |
TRG_ENDOCYTIC_2 | 424 | 427 | PF00928 | 0.390 |
TRG_ENDOCYTIC_2 | 82 | 85 | PF00928 | 0.509 |
TRG_ER_diArg_1 | 157 | 159 | PF00400 | 0.489 |
TRG_ER_diArg_1 | 290 | 292 | PF00400 | 0.298 |
TRG_ER_diArg_1 | 346 | 349 | PF00400 | 0.441 |
TRG_ER_diArg_1 | 430 | 433 | PF00400 | 0.480 |
TRG_ER_diArg_1 | 498 | 501 | PF00400 | 0.503 |
TRG_Pf-PMV_PEXEL_1 | 159 | 164 | PF00026 | 0.497 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P8N9 | Leptomonas seymouri | 28% | 85% |
A0A0N1P921 | Leptomonas seymouri | 25% | 69% |
A0A0S4J2Y5 | Bodo saltans | 24% | 66% |
A0A0S4JC97 | Bodo saltans | 25% | 67% |
A0A1X0P4M6 | Trypanosomatidae | 24% | 96% |
A0A3Q8IAE2 | Leishmania donovani | 100% | 89% |
A0A3S7X2V4 | Leishmania donovani | 28% | 72% |
A4H3R1 | Leishmania braziliensis | 27% | 81% |
C9ZK22 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 24% | 69% |
C9ZS86 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 24% | 100% |
C9ZZI9 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 23% | 92% |
D0A4F4 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 25% | 66% |
E9AEF0 | Leishmania major | 28% | 72% |
E9AHJ6 | Leishmania infantum | 28% | 72% |
Q4QD45 | Leishmania major | 81% | 100% |
Q4QJ80 | Leishmania major | 81% | 100% |
V5BMQ2 | Trypanosoma cruzi | 24% | 100% |